Literature DB >> 1285321

Expression of a Chlamydia anticarbohydrate single-chain antibody as a maltose binding fusion protein.

D P Malinowski1, M Gourley, S Edelstein, R E Pearson.   

Abstract

A single-chain antibody fragment has been constructed for an antibody that binds to the Chlamydia specific carbohydrate structure of the lipopolysaccharide. Single-chain protein was expressed and secreted into the periplasmic space of E. coli as a fusion protein with the maltose binding protein. The fusion protein was purified in one step by virtue of its ability to bind to maltose. In a sandwich ELISA, the eluted protein bound Chlamydia lipopolysaccharide, which demonstrates that the single-chain protein domain will function as part of a fusion protein. The expression of maltose binding fusion proteins into the periplasmic space could be used for production of other single-chain antibodies or protein fragments requiring appropriate folding and disulfide bond formation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1285321     DOI: 10.1007/BF02789473

Source DB:  PubMed          Journal:  Cell Biophys        ISSN: 0163-4992


  13 in total

1.  Expression of functional antibody Fv and Fab fragments in Escherichia coli.

Authors:  A Plückthun; A Skerra
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

2.  Vectors that facilitate the expression and purification of foreign peptides in Escherichia coli by fusion to maltose-binding protein.

Authors:  C di Guan; P Li; P D Riggs; H Inouye
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

3.  An Escherichia coli vector to express and purify foreign proteins by fusion to and separation from maltose-binding protein.

Authors:  C V Maina; P D Riggs; A G Grandea; B E Slatko; L S Moran; J A Tagliamonte; L A McReynolds; C D Guan
Journal:  Gene       Date:  1988-12-30       Impact factor: 3.688

4.  Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli.

Authors:  E S Ward; D Güssow; A D Griffiths; P T Jones; G Winter
Journal:  Nature       Date:  1989-10-12       Impact factor: 49.962

5.  Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.

Authors:  R Orlandi; D H Güssow; P T Jones; G Winter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  A comparison of strategies to stabilize immunoglobulin Fv-fragments.

Authors:  R Glockshuber; M Malia; I Pfitzinger; A Plückthun
Journal:  Biochemistry       Date:  1990-02-13       Impact factor: 3.162

7.  Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

Authors:  J S Huston; D Levinson; M Mudgett-Hunter; M S Tai; J Novotný; M N Margolies; R J Ridge; R E Bruccoleri; E Haber; R Crea
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Structure, serological specificity, and synthesis of artificial glycoconjugates representing the genus-specific lipopolysaccharide epitope of Chlamydia spp.

Authors:  O Holst; L Brade; P Kosma; H Brade
Journal:  J Bacteriol       Date:  1991-03       Impact factor: 3.490

9.  Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide.

Authors:  H D Caldwell; P J Hitchcock
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

10.  Assembly of a functional immunoglobulin Fv fragment in Escherichia coli.

Authors:  A Skerra; A Plückthun
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.